nodes	percent_of_prediction	percent_of_DWPC	metapath
Perhexiline—CYP2D6—Fingolimod—multiple sclerosis	0.165	0.231	CbGbCtD
Perhexiline—CYP3A4—Fingolimod—multiple sclerosis	0.105	0.147	CbGbCtD
Perhexiline—CYP2B6—Dexamethasone—multiple sclerosis	0.0835	0.116	CbGbCtD
Perhexiline—CYP3A4—Methylprednisolone—multiple sclerosis	0.0678	0.0945	CbGbCtD
Perhexiline—CYP3A4—Triamcinolone—multiple sclerosis	0.0514	0.0716	CbGbCtD
Perhexiline—CYP3A4—Mitoxantrone—multiple sclerosis	0.0494	0.0689	CbGbCtD
Perhexiline—CYP3A4—Betamethasone—multiple sclerosis	0.0441	0.0614	CbGbCtD
Perhexiline—CYP3A4—Prednisolone—multiple sclerosis	0.0435	0.0606	CbGbCtD
Perhexiline—CYP3A4—Prednisone—multiple sclerosis	0.0411	0.0572	CbGbCtD
Perhexiline—CYP2D6—Dexamethasone—multiple sclerosis	0.0403	0.0562	CbGbCtD
Perhexiline—CYP3A4—Dexamethasone—multiple sclerosis	0.0256	0.0357	CbGbCtD
Perhexiline—Cachexia—Cladribine—multiple sclerosis	0.0135	0.0547	CcSEcCtD
Perhexiline—Polyneuropathy—Cladribine—multiple sclerosis	0.0118	0.048	CcSEcCtD
Perhexiline—Blood triglycerides increased—Fingolimod—multiple sclerosis	0.0104	0.0421	CcSEcCtD
Perhexiline—Liver injury—Fingolimod—multiple sclerosis	0.00809	0.0328	CcSEcCtD
Perhexiline—Papilloedema—Prednisolone—multiple sclerosis	0.00654	0.0265	CcSEcCtD
Perhexiline—Papilloedema—Triamcinolone—multiple sclerosis	0.00602	0.0244	CcSEcCtD
Perhexiline—Papilloedema—Methylprednisolone—multiple sclerosis	0.006	0.0243	CcSEcCtD
Perhexiline—Papilloedema—Dexamethasone—multiple sclerosis	0.00546	0.0221	CcSEcCtD
Perhexiline—Papilloedema—Betamethasone—multiple sclerosis	0.00546	0.0221	CcSEcCtD
Perhexiline—Papilloedema—Prednisone—multiple sclerosis	0.00475	0.0193	CcSEcCtD
Perhexiline—Weight decreased—Fingolimod—multiple sclerosis	0.00386	0.0157	CcSEcCtD
Perhexiline—Liver injury—Azathioprine—multiple sclerosis	0.00373	0.0151	CcSEcCtD
Perhexiline—CPT2—retina—multiple sclerosis	0.00362	0.139	CbGeAlD
Perhexiline—Optic neuritis—Prednisolone—multiple sclerosis	0.00338	0.0137	CcSEcCtD
Perhexiline—Hepatocellular injury—Azathioprine—multiple sclerosis	0.00314	0.0127	CcSEcCtD
Perhexiline—Optic neuritis—Triamcinolone—multiple sclerosis	0.00311	0.0126	CcSEcCtD
Perhexiline—Optic neuritis—Methylprednisolone—multiple sclerosis	0.0031	0.0126	CcSEcCtD
Perhexiline—Optic neuritis—Dexamethasone—multiple sclerosis	0.00282	0.0114	CcSEcCtD
Perhexiline—Optic neuritis—Betamethasone—multiple sclerosis	0.00282	0.0114	CcSEcCtD
Perhexiline—Ataxia—Cladribine—multiple sclerosis	0.00263	0.0107	CcSEcCtD
Perhexiline—Hypertriglyceridaemia—Prednisone—multiple sclerosis	0.00263	0.0107	CcSEcCtD
Perhexiline—CPT2—medulla oblongata—multiple sclerosis	0.00261	0.101	CbGeAlD
Perhexiline—Muscular weakness—Cladribine—multiple sclerosis	0.00247	0.01	CcSEcCtD
Perhexiline—Optic neuritis—Prednisone—multiple sclerosis	0.00246	0.00996	CcSEcCtD
Perhexiline—CPT2—midbrain—multiple sclerosis	0.00239	0.092	CbGeAlD
Perhexiline—CPT2—spinal cord—multiple sclerosis	0.00233	0.0898	CbGeAlD
Perhexiline—Blood triglycerides increased—Prednisone—multiple sclerosis	0.00231	0.00935	CcSEcCtD
Perhexiline—Paraesthesia—Fingolimod—multiple sclerosis	0.00218	0.00884	CcSEcCtD
Perhexiline—Fatigue—Fingolimod—multiple sclerosis	0.00209	0.00849	CcSEcCtD
Perhexiline—CPT2—nervous system—multiple sclerosis	0.00196	0.0757	CbGeAlD
Perhexiline—CPT1A—cerebellum—multiple sclerosis	0.00195	0.075	CbGeAlD
Perhexiline—CPT2—central nervous system—multiple sclerosis	0.00189	0.0728	CbGeAlD
Perhexiline—CPT2—cerebellum—multiple sclerosis	0.00185	0.0712	CbGeAlD
Perhexiline—Asthenia—Fingolimod—multiple sclerosis	0.00174	0.00706	CcSEcCtD
Perhexiline—Dizziness—Fingolimod—multiple sclerosis	0.00161	0.00651	CcSEcCtD
Perhexiline—CPT1A—brain—multiple sclerosis	0.00158	0.0609	CbGeAlD
Perhexiline—Headache—Fingolimod—multiple sclerosis	0.00152	0.00617	CcSEcCtD
Perhexiline—CPT2—brain—multiple sclerosis	0.0015	0.0578	CbGeAlD
Perhexiline—Weight decreased—Mitoxantrone—multiple sclerosis	0.00144	0.00583	CcSEcCtD
Perhexiline—Sweating—Mitoxantrone—multiple sclerosis	0.00136	0.00551	CcSEcCtD
Perhexiline—Muscular weakness—Prednisolone—multiple sclerosis	0.00133	0.0054	CcSEcCtD
Perhexiline—Hyperhidrosis—Cladribine—multiple sclerosis	0.00133	0.00539	CcSEcCtD
Perhexiline—Anorexia—Cladribine—multiple sclerosis	0.00131	0.00532	CcSEcCtD
Perhexiline—Hepatitis—Mitoxantrone—multiple sclerosis	0.00127	0.00516	CcSEcCtD
Perhexiline—Insomnia—Cladribine—multiple sclerosis	0.00124	0.00505	CcSEcCtD
Perhexiline—Paraesthesia—Cladribine—multiple sclerosis	0.00124	0.00501	CcSEcCtD
Perhexiline—Muscular weakness—Triamcinolone—multiple sclerosis	0.00122	0.00497	CcSEcCtD
Perhexiline—Muscular weakness—Methylprednisolone—multiple sclerosis	0.00122	0.00495	CcSEcCtD
Perhexiline—Decreased appetite—Cladribine—multiple sclerosis	0.0012	0.00485	CcSEcCtD
Perhexiline—Fatigue—Cladribine—multiple sclerosis	0.00119	0.00481	CcSEcCtD
Perhexiline—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.00114	0.00462	CcSEcCtD
Perhexiline—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00113	0.00456	CcSEcCtD
Perhexiline—Muscular weakness—Dexamethasone—multiple sclerosis	0.00111	0.00451	CcSEcCtD
Perhexiline—Muscular weakness—Betamethasone—multiple sclerosis	0.00111	0.00451	CcSEcCtD
Perhexiline—Urticaria—Cladribine—multiple sclerosis	0.00109	0.00443	CcSEcCtD
Perhexiline—Abdominal pain—Cladribine—multiple sclerosis	0.00109	0.00441	CcSEcCtD
Perhexiline—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.00105	0.00425	CcSEcCtD
Perhexiline—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.00105	0.00424	CcSEcCtD
Perhexiline—Sweating—Methylprednisolone—multiple sclerosis	0.00102	0.00415	CcSEcCtD
Perhexiline—Asthenia—Cladribine—multiple sclerosis	0.000987	0.004	CcSEcCtD
Perhexiline—Weight decreased—Dexamethasone—multiple sclerosis	0.000985	0.00399	CcSEcCtD
Perhexiline—Weight decreased—Betamethasone—multiple sclerosis	0.000985	0.00399	CcSEcCtD
Perhexiline—Muscular weakness—Prednisone—multiple sclerosis	0.000968	0.00392	CcSEcCtD
Perhexiline—Convulsion—Mitoxantrone—multiple sclerosis	0.00096	0.00389	CcSEcCtD
Perhexiline—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000952	0.00386	CcSEcCtD
Perhexiline—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000952	0.00386	CcSEcCtD
Perhexiline—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000915	0.00371	CcSEcCtD
Perhexiline—Dizziness—Cladribine—multiple sclerosis	0.00091	0.00369	CcSEcCtD
Perhexiline—Shock—Mitoxantrone—multiple sclerosis	0.00089	0.00361	CcSEcCtD
Perhexiline—Abdominal pain—Azathioprine—multiple sclerosis	0.000885	0.00359	CcSEcCtD
Perhexiline—Vomiting—Cladribine—multiple sclerosis	0.000875	0.00355	CcSEcCtD
Perhexiline—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000875	0.00355	CcSEcCtD
Perhexiline—Rash—Cladribine—multiple sclerosis	0.000868	0.00352	CcSEcCtD
Perhexiline—Dermatitis—Cladribine—multiple sclerosis	0.000867	0.00351	CcSEcCtD
Perhexiline—Anorexia—Mitoxantrone—multiple sclerosis	0.000862	0.0035	CcSEcCtD
Perhexiline—Ataxia—Methotrexate—multiple sclerosis	0.000862	0.0035	CcSEcCtD
Perhexiline—Headache—Cladribine—multiple sclerosis	0.000862	0.0035	CcSEcCtD
Perhexiline—Weight decreased—Prednisone—multiple sclerosis	0.000858	0.00348	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000851	0.0841	CbGpPWpGaD
Perhexiline—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000829	0.00336	CcSEcCtD
Perhexiline—Nausea—Cladribine—multiple sclerosis	0.000817	0.00331	CcSEcCtD
Perhexiline—Syncope—Prednisolone—multiple sclerosis	0.000815	0.00331	CcSEcCtD
Perhexiline—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000812	0.00329	CcSEcCtD
Perhexiline—Loss of consciousness—Prednisolone—multiple sclerosis	0.000799	0.00324	CcSEcCtD
Perhexiline—Convulsion—Prednisolone—multiple sclerosis	0.000788	0.00319	CcSEcCtD
Perhexiline—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000786	0.00319	CcSEcCtD
Perhexiline—Fatigue—Mitoxantrone—multiple sclerosis	0.00078	0.00316	CcSEcCtD
Perhexiline—Syncope—Triamcinolone—multiple sclerosis	0.00075	0.00304	CcSEcCtD
Perhexiline—Syncope—Methylprednisolone—multiple sclerosis	0.000748	0.00303	CcSEcCtD
Perhexiline—Dizziness—Azathioprine—multiple sclerosis	0.00074	0.003	CcSEcCtD
Perhexiline—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00074	0.003	CcSEcCtD
Perhexiline—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000735	0.00298	CcSEcCtD
Perhexiline—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000733	0.00297	CcSEcCtD
Perhexiline—Shock—Prednisolone—multiple sclerosis	0.00073	0.00296	CcSEcCtD
Perhexiline—CYP2D6—brainstem—multiple sclerosis	0.000725	0.0279	CbGeAlD
Perhexiline—Convulsion—Triamcinolone—multiple sclerosis	0.000725	0.00294	CcSEcCtD
Perhexiline—Convulsion—Methylprednisolone—multiple sclerosis	0.000723	0.00293	CcSEcCtD
Perhexiline—Urticaria—Mitoxantrone—multiple sclerosis	0.000719	0.00291	CcSEcCtD
Perhexiline—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000717	0.00291	CcSEcCtD
Perhexiline—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000715	0.0029	CcSEcCtD
Perhexiline—Vomiting—Azathioprine—multiple sclerosis	0.000711	0.00288	CcSEcCtD
Perhexiline—Rash—Azathioprine—multiple sclerosis	0.000706	0.00286	CcSEcCtD
Perhexiline—Dermatitis—Azathioprine—multiple sclerosis	0.000705	0.00286	CcSEcCtD
Perhexiline—Flushing—Prednisone—multiple sclerosis	0.000704	0.00286	CcSEcCtD
Perhexiline—Headache—Azathioprine—multiple sclerosis	0.000701	0.00284	CcSEcCtD
Perhexiline—Syncope—Betamethasone—multiple sclerosis	0.00068	0.00276	CcSEcCtD
Perhexiline—Syncope—Dexamethasone—multiple sclerosis	0.00068	0.00276	CcSEcCtD
Perhexiline—Sweating—Methotrexate—multiple sclerosis	0.000677	0.00275	CcSEcCtD
Perhexiline—Shock—Triamcinolone—multiple sclerosis	0.000671	0.00272	CcSEcCtD
Perhexiline—Insomnia—Prednisolone—multiple sclerosis	0.000671	0.00272	CcSEcCtD
Perhexiline—Shock—Methylprednisolone—multiple sclerosis	0.00067	0.00272	CcSEcCtD
Perhexiline—Loss of consciousness—Betamethasone—multiple sclerosis	0.000667	0.0027	CcSEcCtD
Perhexiline—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000667	0.0027	CcSEcCtD
Perhexiline—Paraesthesia—Prednisolone—multiple sclerosis	0.000666	0.0027	CcSEcCtD
Perhexiline—Nausea—Azathioprine—multiple sclerosis	0.000665	0.00269	CcSEcCtD
Perhexiline—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00066	0.00267	CcSEcCtD
Perhexiline—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000658	0.00267	CcSEcCtD
Perhexiline—Convulsion—Betamethasone—multiple sclerosis	0.000657	0.00267	CcSEcCtD
Perhexiline—Convulsion—Dexamethasone—multiple sclerosis	0.000657	0.00267	CcSEcCtD
Perhexiline—Asthenia—Mitoxantrone—multiple sclerosis	0.000649	0.00263	CcSEcCtD
Perhexiline—Hepatitis—Methotrexate—multiple sclerosis	0.000634	0.00257	CcSEcCtD
Perhexiline—Insomnia—Triamcinolone—multiple sclerosis	0.000617	0.0025	CcSEcCtD
Perhexiline—Insomnia—Methylprednisolone—multiple sclerosis	0.000616	0.0025	CcSEcCtD
Perhexiline—Paraesthesia—Triamcinolone—multiple sclerosis	0.000613	0.00248	CcSEcCtD
Perhexiline—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000611	0.00248	CcSEcCtD
Perhexiline—Shock—Betamethasone—multiple sclerosis	0.000609	0.00247	CcSEcCtD
Perhexiline—Shock—Dexamethasone—multiple sclerosis	0.000609	0.00247	CcSEcCtD
Perhexiline—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000599	0.00243	CcSEcCtD
Perhexiline—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000599	0.00243	CcSEcCtD
Perhexiline—Syncope—Prednisone—multiple sclerosis	0.000593	0.0024	CcSEcCtD
Perhexiline—Anorexia—Dexamethasone—multiple sclerosis	0.00059	0.00239	CcSEcCtD
Perhexiline—Anorexia—Betamethasone—multiple sclerosis	0.00059	0.00239	CcSEcCtD
Perhexiline—Urticaria—Prednisolone—multiple sclerosis	0.00059	0.00239	CcSEcCtD
Perhexiline—Fatigue—Triamcinolone—multiple sclerosis	0.000588	0.00239	CcSEcCtD
Perhexiline—Fatigue—Methylprednisolone—multiple sclerosis	0.000587	0.00238	CcSEcCtD
Perhexiline—Loss of consciousness—Prednisone—multiple sclerosis	0.000581	0.00235	CcSEcCtD
Perhexiline—Vomiting—Mitoxantrone—multiple sclerosis	0.000575	0.00233	CcSEcCtD
Perhexiline—Convulsion—Prednisone—multiple sclerosis	0.000573	0.00232	CcSEcCtD
Perhexiline—Rash—Mitoxantrone—multiple sclerosis	0.00057	0.00231	CcSEcCtD
Perhexiline—Dermatitis—Mitoxantrone—multiple sclerosis	0.00057	0.00231	CcSEcCtD
Perhexiline—Headache—Mitoxantrone—multiple sclerosis	0.000567	0.0023	CcSEcCtD
Perhexiline—Insomnia—Dexamethasone—multiple sclerosis	0.00056	0.00227	CcSEcCtD
Perhexiline—Insomnia—Betamethasone—multiple sclerosis	0.00056	0.00227	CcSEcCtD
Perhexiline—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000557	0.00226	CcSEcCtD
Perhexiline—Paraesthesia—Dexamethasone—multiple sclerosis	0.000556	0.00225	CcSEcCtD
Perhexiline—Paraesthesia—Betamethasone—multiple sclerosis	0.000556	0.00225	CcSEcCtD
Perhexiline—Urticaria—Triamcinolone—multiple sclerosis	0.000542	0.0022	CcSEcCtD
Perhexiline—Urticaria—Methylprednisolone—multiple sclerosis	0.000541	0.00219	CcSEcCtD
Perhexiline—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000538	0.00218	CcSEcCtD
Perhexiline—Decreased appetite—Dexamethasone—multiple sclerosis	0.000538	0.00218	CcSEcCtD
Perhexiline—Decreased appetite—Betamethasone—multiple sclerosis	0.000538	0.00218	CcSEcCtD
Perhexiline—Nausea—Mitoxantrone—multiple sclerosis	0.000537	0.00218	CcSEcCtD
Perhexiline—Fatigue—Dexamethasone—multiple sclerosis	0.000534	0.00216	CcSEcCtD
Perhexiline—Fatigue—Betamethasone—multiple sclerosis	0.000534	0.00216	CcSEcCtD
Perhexiline—Shock—Prednisone—multiple sclerosis	0.000531	0.00215	CcSEcCtD
Perhexiline—Hyperhidrosis—Prednisone—multiple sclerosis	0.000521	0.00211	CcSEcCtD
Perhexiline—Anorexia—Prednisone—multiple sclerosis	0.000514	0.00208	CcSEcCtD
Perhexiline—CYP2B6—nervous system—multiple sclerosis	0.000511	0.0197	CbGeAlD
Perhexiline—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000506	0.00205	CcSEcCtD
Perhexiline—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000506	0.00205	CcSEcCtD
Perhexiline—CYP2B6—central nervous system—multiple sclerosis	0.000492	0.019	CbGeAlD
Perhexiline—Urticaria—Dexamethasone—multiple sclerosis	0.000492	0.00199	CcSEcCtD
Perhexiline—Urticaria—Betamethasone—multiple sclerosis	0.000492	0.00199	CcSEcCtD
Perhexiline—Dizziness—Prednisolone—multiple sclerosis	0.000491	0.00199	CcSEcCtD
Perhexiline—Asthenia—Triamcinolone—multiple sclerosis	0.00049	0.00199	CcSEcCtD
Perhexiline—Abdominal pain—Dexamethasone—multiple sclerosis	0.00049	0.00198	CcSEcCtD
Perhexiline—Abdominal pain—Betamethasone—multiple sclerosis	0.00049	0.00198	CcSEcCtD
Perhexiline—Asthenia—Methylprednisolone—multiple sclerosis	0.000489	0.00198	CcSEcCtD
Perhexiline—Insomnia—Prednisone—multiple sclerosis	0.000488	0.00198	CcSEcCtD
Perhexiline—Paraesthesia—Prednisone—multiple sclerosis	0.000484	0.00196	CcSEcCtD
Perhexiline—Convulsion—Methotrexate—multiple sclerosis	0.000478	0.00194	CcSEcCtD
Perhexiline—Decreased appetite—Prednisone—multiple sclerosis	0.000469	0.0019	CcSEcCtD
Perhexiline—Rash—Prednisolone—multiple sclerosis	0.000468	0.0019	CcSEcCtD
Perhexiline—Dermatitis—Prednisolone—multiple sclerosis	0.000468	0.0019	CcSEcCtD
Perhexiline—Fatigue—Prednisone—multiple sclerosis	0.000465	0.00189	CcSEcCtD
Perhexiline—Headache—Prednisolone—multiple sclerosis	0.000465	0.00188	CcSEcCtD
Perhexiline—Dizziness—Triamcinolone—multiple sclerosis	0.000451	0.00183	CcSEcCtD
Perhexiline—Dizziness—Methylprednisolone—multiple sclerosis	0.00045	0.00183	CcSEcCtD
Perhexiline—Asthenia—Betamethasone—multiple sclerosis	0.000444	0.0018	CcSEcCtD
Perhexiline—Asthenia—Dexamethasone—multiple sclerosis	0.000444	0.0018	CcSEcCtD
Perhexiline—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000441	0.00179	CcSEcCtD
Perhexiline—Nausea—Prednisolone—multiple sclerosis	0.000441	0.00179	CcSEcCtD
Perhexiline—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000436	0.00177	CcSEcCtD
Perhexiline—Vomiting—Triamcinolone—multiple sclerosis	0.000434	0.00176	CcSEcCtD
Perhexiline—Vomiting—Methylprednisolone—multiple sclerosis	0.000433	0.00176	CcSEcCtD
Perhexiline—Rash—Triamcinolone—multiple sclerosis	0.00043	0.00174	CcSEcCtD
Perhexiline—Dermatitis—Triamcinolone—multiple sclerosis	0.00043	0.00174	CcSEcCtD
Perhexiline—Anorexia—Methotrexate—multiple sclerosis	0.00043	0.00174	CcSEcCtD
Perhexiline—Rash—Methylprednisolone—multiple sclerosis	0.000429	0.00174	CcSEcCtD
Perhexiline—Dermatitis—Methylprednisolone—multiple sclerosis	0.000429	0.00174	CcSEcCtD
Perhexiline—Urticaria—Prednisone—multiple sclerosis	0.000428	0.00174	CcSEcCtD
Perhexiline—Headache—Triamcinolone—multiple sclerosis	0.000428	0.00173	CcSEcCtD
Perhexiline—Headache—Methylprednisolone—multiple sclerosis	0.000427	0.00173	CcSEcCtD
Perhexiline—Abdominal pain—Prednisone—multiple sclerosis	0.000426	0.00173	CcSEcCtD
Perhexiline—Dizziness—Dexamethasone—multiple sclerosis	0.00041	0.00166	CcSEcCtD
Perhexiline—Dizziness—Betamethasone—multiple sclerosis	0.00041	0.00166	CcSEcCtD
Perhexiline—Insomnia—Methotrexate—multiple sclerosis	0.000408	0.00165	CcSEcCtD
Perhexiline—Nausea—Triamcinolone—multiple sclerosis	0.000405	0.00164	CcSEcCtD
Perhexiline—Paraesthesia—Methotrexate—multiple sclerosis	0.000405	0.00164	CcSEcCtD
Perhexiline—Nausea—Methylprednisolone—multiple sclerosis	0.000404	0.00164	CcSEcCtD
Perhexiline—Vomiting—Betamethasone—multiple sclerosis	0.000394	0.0016	CcSEcCtD
Perhexiline—Vomiting—Dexamethasone—multiple sclerosis	0.000394	0.0016	CcSEcCtD
Perhexiline—Decreased appetite—Methotrexate—multiple sclerosis	0.000392	0.00159	CcSEcCtD
Perhexiline—CYP2B6—brain—multiple sclerosis	0.000391	0.015	CbGeAlD
Perhexiline—Rash—Betamethasone—multiple sclerosis	0.00039	0.00158	CcSEcCtD
Perhexiline—Rash—Dexamethasone—multiple sclerosis	0.00039	0.00158	CcSEcCtD
Perhexiline—Dermatitis—Betamethasone—multiple sclerosis	0.00039	0.00158	CcSEcCtD
Perhexiline—Dermatitis—Dexamethasone—multiple sclerosis	0.00039	0.00158	CcSEcCtD
Perhexiline—Fatigue—Methotrexate—multiple sclerosis	0.000389	0.00158	CcSEcCtD
Perhexiline—Headache—Dexamethasone—multiple sclerosis	0.000388	0.00157	CcSEcCtD
Perhexiline—Headache—Betamethasone—multiple sclerosis	0.000388	0.00157	CcSEcCtD
Perhexiline—Asthenia—Prednisone—multiple sclerosis	0.000387	0.00157	CcSEcCtD
Perhexiline—CYP3A4—nervous system—multiple sclerosis	0.000386	0.0149	CbGeAlD
Perhexiline—CYP2D6—nervous system—multiple sclerosis	0.00038	0.0146	CbGeAlD
Perhexiline—CYP3A4—central nervous system—multiple sclerosis	0.000372	0.0143	CbGeAlD
Perhexiline—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000369	0.00149	CcSEcCtD
Perhexiline—Nausea—Dexamethasone—multiple sclerosis	0.000368	0.00149	CcSEcCtD
Perhexiline—Nausea—Betamethasone—multiple sclerosis	0.000368	0.00149	CcSEcCtD
Perhexiline—CYP2D6—central nervous system—multiple sclerosis	0.000366	0.0141	CbGeAlD
Perhexiline—Urticaria—Methotrexate—multiple sclerosis	0.000358	0.00145	CcSEcCtD
Perhexiline—CYP2D6—cerebellum—multiple sclerosis	0.000358	0.0138	CbGeAlD
Perhexiline—Dizziness—Prednisone—multiple sclerosis	0.000357	0.00145	CcSEcCtD
Perhexiline—Abdominal pain—Methotrexate—multiple sclerosis	0.000356	0.00144	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000353	0.0349	CbGpPWpGaD
Perhexiline—Vomiting—Prednisone—multiple sclerosis	0.000343	0.00139	CcSEcCtD
Perhexiline—Rash—Prednisone—multiple sclerosis	0.00034	0.00138	CcSEcCtD
Perhexiline—Dermatitis—Prednisone—multiple sclerosis	0.00034	0.00138	CcSEcCtD
Perhexiline—Headache—Prednisone—multiple sclerosis	0.000338	0.00137	CcSEcCtD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000333	0.0329	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000333	0.0329	CbGpPWpGaD
Perhexiline—CPT2—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000327	0.0323	CbGpPWpGaD
Perhexiline—Asthenia—Methotrexate—multiple sclerosis	0.000323	0.00131	CcSEcCtD
Perhexiline—Nausea—Prednisone—multiple sclerosis	0.00032	0.0013	CcSEcCtD
Perhexiline—Dizziness—Methotrexate—multiple sclerosis	0.000298	0.00121	CcSEcCtD
Perhexiline—CYP2D6—brain—multiple sclerosis	0.00029	0.0112	CbGeAlD
Perhexiline—Vomiting—Methotrexate—multiple sclerosis	0.000287	0.00116	CcSEcCtD
Perhexiline—Rash—Methotrexate—multiple sclerosis	0.000284	0.00115	CcSEcCtD
Perhexiline—Dermatitis—Methotrexate—multiple sclerosis	0.000284	0.00115	CcSEcCtD
Perhexiline—Headache—Methotrexate—multiple sclerosis	0.000282	0.00114	CcSEcCtD
Perhexiline—Nausea—Methotrexate—multiple sclerosis	0.000268	0.00109	CcSEcCtD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000268	0.0265	CbGpPWpGaD
Perhexiline—CPT1A—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.000235	0.0232	CbGpPWpGaD
Perhexiline—CPT1A—PPAR Alpha Pathway—MYC—multiple sclerosis	0.000226	0.0224	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000213	0.0211	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000213	0.0211	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000211	0.0209	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000211	0.0209	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000208	0.0206	CbGpPWpGaD
Perhexiline—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000208	0.0206	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000171	0.0169	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000171	0.0169	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000151	0.0149	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000151	0.0149	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000148	0.0146	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000148	0.0146	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000147	0.0145	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000147	0.0145	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000145	0.0143	CbGpPWpGaD
Perhexiline—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000145	0.0143	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000138	0.0137	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—SRM—multiple sclerosis	0.000135	0.0133	CbGpPWpGaD
Perhexiline—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000134	0.0132	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000132	0.0131	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000119	0.0118	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000119	0.0118	CbGpPWpGaD
Perhexiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000109	0.0108	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—FAS—multiple sclerosis	9.68e-05	0.00957	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	9.59e-05	0.00949	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	9.59e-05	0.00949	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP27B1—multiple sclerosis	9.48e-05	0.00938	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—CYP24A1—multiple sclerosis	9.48e-05	0.00938	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	9.47e-05	0.00936	CbGpPWpGaD
Perhexiline—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	9.47e-05	0.00936	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—SRM—multiple sclerosis	9.33e-05	0.00922	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	9.26e-05	0.00916	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	9.09e-05	0.00899	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	9.09e-05	0.00899	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.97e-05	0.00887	CbGpPWpGaD
Perhexiline—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.97e-05	0.00887	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—GPC5—multiple sclerosis	8.67e-05	0.00857	CbGpPWpGaD
Perhexiline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	8.61e-05	0.00851	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	7.78e-05	0.00769	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	7.78e-05	0.00769	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—RRM1—multiple sclerosis	7.18e-05	0.00711	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	6.93e-05	0.00686	CbGpPWpGaD
Perhexiline—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	6.87e-05	0.0068	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP27B1—multiple sclerosis	6.57e-05	0.0065	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—CYP24A1—multiple sclerosis	6.57e-05	0.0065	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.42e-05	0.00635	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	6.32e-05	0.00625	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	6.32e-05	0.00625	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.23e-05	0.00616	CbGpPWpGaD
Perhexiline—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.23e-05	0.00616	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—GPC5—multiple sclerosis	6.01e-05	0.00594	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.57e-05	0.00551	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.03e-05	0.00498	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—RRM1—multiple sclerosis	4.98e-05	0.00492	CbGpPWpGaD
Perhexiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.94e-05	0.00489	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.79e-05	0.00474	CbGpPWpGaD
Perhexiline—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.75e-05	0.0047	CbGpPWpGaD
Perhexiline—CPT2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.37e-05	0.00432	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.13e-05	0.00409	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.13e-05	0.00409	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—BCHE—multiple sclerosis	4.13e-05	0.00408	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.07e-05	0.00403	CbGpPWpGaD
Perhexiline—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.07e-05	0.00403	CbGpPWpGaD
Perhexiline—CPT1A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.06e-05	0.00402	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.86e-05	0.00382	CbGpPWpGaD
Perhexiline—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.85e-05	0.00381	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.32e-05	0.00328	CbGpPWpGaD
Perhexiline—CPT1A—Circadian rythm related genes—IL6—multiple sclerosis	3.32e-05	0.00328	CbGpPWpGaD
Perhexiline—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.3e-05	0.00326	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.03e-05	0.00299	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—BCHE—multiple sclerosis	2.86e-05	0.00283	CbGpPWpGaD
Perhexiline—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.68e-05	0.00265	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—APOE—multiple sclerosis	2.48e-05	0.00246	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—SRM—multiple sclerosis	2.21e-05	0.00218	CbGpPWpGaD
Perhexiline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.16e-05	0.00213	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—POMC—multiple sclerosis	2.13e-05	0.00211	CbGpPWpGaD
Perhexiline—CYP2B6—Biological oxidations—POMC—multiple sclerosis	2.05e-05	0.00202	CbGpPWpGaD
Perhexiline—CPT2—Metabolism—ALB—multiple sclerosis	1.94e-05	0.00192	CbGpPWpGaD
Perhexiline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.75e-05	0.00173	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—APOE—multiple sclerosis	1.72e-05	0.0017	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	1.55e-05	0.00154	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	1.55e-05	0.00154	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—SRM—multiple sclerosis	1.53e-05	0.00152	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—POMC—multiple sclerosis	1.48e-05	0.00146	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—GPC5—multiple sclerosis	1.42e-05	0.00141	CbGpPWpGaD
Perhexiline—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.42e-05	0.00141	CbGpPWpGaD
Perhexiline—CPT1A—Metabolism—ALB—multiple sclerosis	1.35e-05	0.00133	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.18e-05	0.00117	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.08e-05	0.00107	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.08e-05	0.00107	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—SRM—multiple sclerosis	1e-05	0.000992	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—GPC5—multiple sclerosis	9.88e-06	0.000978	CbGpPWpGaD
Perhexiline—CYP3A4—Biological oxidations—POMC—multiple sclerosis	9.29e-06	0.000919	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—RRM1—multiple sclerosis	8.19e-06	0.00081	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	7.07e-06	0.000699	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	7.07e-06	0.000699	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—BCHE—multiple sclerosis	6.77e-06	0.000669	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—GPC5—multiple sclerosis	6.46e-06	0.000639	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—RRM1—multiple sclerosis	5.35e-06	0.00053	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—BCHE—multiple sclerosis	4.7e-06	0.000465	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—APOE—multiple sclerosis	4.07e-06	0.000403	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—POMC—multiple sclerosis	3.5e-06	0.000346	CbGpPWpGaD
Perhexiline—CYP2B6—Metabolism—ALB—multiple sclerosis	3.19e-06	0.000315	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.08e-06	0.000304	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—APOE—multiple sclerosis	2.83e-06	0.00028	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—POMC—multiple sclerosis	2.43e-06	0.00024	CbGpPWpGaD
Perhexiline—CYP2D6—Metabolism—ALB—multiple sclerosis	2.22e-06	0.000219	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—APOE—multiple sclerosis	1.85e-06	0.000183	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—POMC—multiple sclerosis	1.59e-06	0.000157	CbGpPWpGaD
Perhexiline—CYP3A4—Metabolism—ALB—multiple sclerosis	1.45e-06	0.000143	CbGpPWpGaD
